DocGo shares fall after worse Q2 results, FY2026 sales guidance narrows
DocGo reports worse-than-expected Q2 financial results and narrows its FY2026 sales guidance, prompting shares to trade lower, per Alpaca Benzinga Live.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.